[Technical specifications for post-marketing pharmacoeconomic evaluation of Chinese medicine (draft version for comments)].
Pharmacoeconomics is an important part of the post-marketing evaluation of Chinese medicine, post-marketing pharmacoeconomic evaluation can better reflect the clinical and market value of Chinese medicine, the purpose of establishing the technical specifications for pharmacoeconomic evaluation is to make the evaluation process and results regarding Chinese patent medicines more scientific and fair. Every country's technical specifications for pharmacoeconomic evaluation act as reference guidelines, we have already drawn up the technical specifications which take into account the special characteristics of Chinese medicine; these are in preparation for post-marketing pharmacoeconomic evaluation Chinese medicine.
Institute of Basic Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing 100875, China.
Yan-Ming
YM
Xie
Institute of Basic Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing 100875, China.
Xin
X
Wang
Beijing Normal University, Beijing 100875, China.
Nuo
N
Wang
Institute of Basic Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing 100875, China.
Yan-Peng
YP
Chang
D002681:China; D003362:Cost-Benefit Analysis; D016903:Drug Monitoring / Q000191:economics / Q000592:standards; D004365:Drugs, Chinese Herbal / Q000191:economics* / Q000592:standards; D017850:Economics, Pharmaceutical; D006801:Humans; D011358:Product Surveillance, Postmarketing / Q000191:economics* / Q000592:standards
D004365:Drugs, Chinese Herbal